atorvastatin has been researched along with Vascular Diseases in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bellini, R; Biagioli, M; Bordoni, M; Di Giorgio, C; Distrutti, E; Fiorucci, S; Marchianò, S; Monti, MC; Morretta, E; Roselli, R; Zampella, A | 1 |
| Atsumi, W; Hayashida, S; Iida, K; Iso, K; Kunimoto, S; Kuronuma, K; Matsumoto, N; Okumura, Y; Sakatani, K; Sugai, S; Suzuki, Y; Tachibana, E; Tani, S; Yagi, T | 1 |
| Amarenco, P; Callahan, A; Goldstein, LB; Hennerici, MG; Messig, M; Ovbiagele, B; Sillesen, H; Welch, KM; Zivin, J | 1 |
| Ahmed, Z; Bajwa, A; Bhardwaj, B; Laster, SB; Magalski, A | 1 |
| Liu, W; Wu, S; Zhou, Y | 1 |
| Berringer, R; Wonnacott, D | 1 |
| Mikhailidis, DP; Paraskevas, KI; Veith, FJ | 1 |
| El-Bassossy, HM; El-Nagar, M; Mahmoud, MF | 1 |
| Ai, J; Ban, X; Niu, H; Sun, L; Wang, N; Xu, Y; Yang, B; Yu, Y; Zhang, R; Zhao, R | 1 |
| Lee, JD; Mikhailidis, DP; Morrissey, JR; Patel, V | 1 |
| Jarernsiripornkul, N; Kiatchusakul, S; Ojongpian, S; Srinakarin, J; Tantikosoom, W; Thinkhamrop, B | 1 |
| Császár, A | 1 |
| Aznaouridis, K; Dagre, A; Masoura, C; Pitsavos, C; Skoumas, J; Stefanadi, E; Stefanadis, C; Vasiliadou, C; Vlachopoulos, C | 1 |
| Day, CA; Funovics, P; Heeba, G; Jacob, RF; Kubant, R; Malinski, T; Mason, RP; Medlin, YS | 1 |
4 review(s) available for atorvastatin and Vascular Diseases
| Article | Year |
|---|---|
Spontaneous coronary artery dissection: the management dilemma continues.
Topics: Adenosine; Adult; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Carbazoles; Carvedilol; Coronary Angiography; Coronary Vessel Anomalies; Diagnosis, Differential; Echocardiography; Electrocardiography; Female; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Propanolamines; Purinergic P2Y Receptor Antagonists; Ticagrelor; Vascular Diseases | 2015 |
Spontaneous coronary artery dissection: Case report and review of the literature.
Topics: Acute Coronary Syndrome; Adrenergic beta-1 Receptor Antagonists; Adult; Aspirin; Atorvastatin; Clopidogrel; Coronary Angiography; Coronary Vessel Anomalies; Echocardiography; Electrocardiography; Female; Humans; Metoprolol; Platelet Aggregation Inhibitors; Ticlopidine; Vascular Diseases | 2016 |
Optimal statin type and dosage for vascular patients.
Topics: Atorvastatin; Dose-Response Relationship, Drug; Drug Tolerance; Endovascular Procedures; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Patient Selection; Pyrimidines; Pyrroles; Risk Assessment; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Vascular Diseases; Vascular Surgical Procedures | 2011 |
[Vascular pleiosynergism--a new concept?].
Topics: Amlodipine; Antihypertensive Agents; Atorvastatin; Calcium Channel Blockers; Carrier Proteins; Cell Movement; Cell Proliferation; Cytokines; Endothelium, Vascular; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Myocytes, Smooth Muscle; Nitric Oxide; Nitric Oxide Synthase Type III; Pyrroles; Reactive Oxygen Species; Vascular Diseases | 2006 |
3 trial(s) available for atorvastatin and Vascular Diseases
| Article | Year |
|---|---|
Prediction of major vascular events after stroke: the stroke prevention by aggressive reduction in cholesterol levels trial.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Coronary Disease; Female; Follow-Up Studies; Heptanoic Acids; Humans; Ischemic Attack, Transient; Male; Middle Aged; Prognosis; Pyrroles; Risk Assessment; Stroke; Treatment Outcome; Vascular Diseases | 2014 |
Randomized trial of atorvastatin in improving endothelial function in diabetics without prior coronary disease and having average cholesterol level.
Topics: Atorvastatin; Coronary Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Outpatients; Pyrroles; Vascular Diseases | 2005 |
Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaemic subjects.
Topics: Adult; Atorvastatin; Brachial Artery; Double-Blind Method; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Oxidative Stress; Pyrroles; Salmonella typhi; Salmonella Vaccines; Systemic Inflammatory Response Syndrome; Vascular Diseases; Vasodilation | 2007 |
7 other study(ies) available for atorvastatin and Vascular Diseases
| Article | Year |
|---|---|
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling.
Topics: Animals; Atorvastatin; Bacteria; Bile Acids and Salts; Cholesterol 7-alpha-Hydroxylase; Cholesterol, Dietary; Fatty Liver; Gastrointestinal Microbiome; Liver; Male; Mice; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Signal Transduction; Steroid 12-alpha-Hydroxylase; Vascular Diseases | 2022 |
Effect of Atorvastatin on Microcirculation Evaluated by Vascular Occlusion Test with Peripheral Near-Infrared Spectroscopy.
Topics: Aged; Atorvastatin; Cholesterol, LDL; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Microcirculation; Middle Aged; Oxygen Consumption; Spectroscopy, Near-Infrared; Vascular Diseases | 2022 |
Spontaneous coronary artery dissection in the presence of myocardial bridge causing myocardial infarction: an insight into mechanism.
Topics: Adult; Aspirin; Atorvastatin; Clopidogrel; Coronary Angiography; Coronary Vessel Anomalies; Female; Humans; Myocardial Bridging; Myocardial Infarction; Perindopril; Ticlopidine; Treatment Outcome; Vascular Diseases | 2016 |
Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta, Thoracic; Atorvastatin; Dietary Sucrose; Fructose; Heptanoic Acids; Insulin Resistance; Male; Pyrroles; Rats; Rats, Wistar; Vascular Diseases | 2012 |
Daming capsule restores endothelial dysfunction induced by high-fat diet.
Topics: Animals; Anticholesteremic Agents; Aorta, Thoracic; Atorvastatin; Diet, High-Fat; Drugs, Chinese Herbal; Endothelium, Vascular; Enzyme Inhibitors; Heptanoic Acids; Hyperlipidemias; Hypolipidemic Agents; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phytotherapy; Potassium Channels; Pyrroles; Rats; Rats, Wistar; Vascular Diseases; Vasoconstriction; Vasodilation | 2012 |
CARDS on the table: should everybody with type 2 diabetes take a statin?
Topics: Atorvastatin; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus, Type 2; Evidence-Based Medicine; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Risk Factors; Vascular Diseases | 2005 |
Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunction.
Topics: Amlodipine; Atorvastatin; Blotting, Western; Calcium Channel Blockers; Cells, Cultured; Drug Synergism; Endothelium, Vascular; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Bilayers; Lipoproteins, LDL; Membrane Lipids; Nitric Oxide; Nitric Oxide Synthase Type III; Peroxynitrous Acid; Pyrroles; Vascular Diseases; X-Ray Diffraction | 2008 |